Sta znaci na Engleskom PRILAGODBA DOZIRANJA - prevod na Енглеском

• dosage adjustment
• dosing adjustment

Примери коришћења Prilagodba doziranja на Хрватском и њихови преводи на Енглески

Nije nužna prilagodba doziranja.
No dose adjustment is required.

Prilagodba doziranja u ovih bolesnika nije neophodna.
No dosage adjustment is necessary in these patients.

Nije nužna prilagodba doziranja.
No dose adjustment is recommended.

Kod bolesnika s blagim oštećenjem jetre nije potrebna prilagodba doziranja.
No posology adjustment is required in patients with mild hepatic impairment.

Nije potrebna prilagodba doziranja u žena.
No dosage adjustment is necessary in female patients.

Međutim, dostupno kliničko iskustvo u ove populacije bolesnika nije pokazalo da je potrebna prilagodba doziranja.
However, the clinical experience available in this patient population has not shown the necessity for any dosage adjustment.

Nije potrebna prilagodba doziranja u bolesnica.
No dosage adjustment is necessary in female patients.

Stariji bolesnici- nije potrebna prilagodba doziranja.
Elderly patients- No dosing adjustment is necessary.

Nije potrebna prilagodba doziranja u bolesnika koji uzimaju slabe inhibitore CYP3A4.
No dosage adjustment is required for patients taking weak CYP3A4 inhibitors.

Prevencija VTE i liječenje UA/NSTEMI i STEMI- nije potrebna prilagodba doziranja fondaparinuksa.
Prevention of VTE and Treatment of UA/NSTEMI and STEMI- Dosing adjustment of fondaparinux is not necessary.

Stoga se ne preporučuje prilagodba doziranja u bolesnika s oštećenjem fukcije jetre.
Therefore, no dosage adjustment is recommended for patients with hepatic impairment.

Podaci o sigurnosti i djelotvornosti u bolesnika u dobi od 65 i više godina ukazuju na to da nije potrebna prilagodba doziranja u tih bolesnika vidjeti dio 5.2.
Safety and efficacy data in patients aged 65 years and older do not suggest that a dosage adjustment is required in these patients see section 5.2.

Prevencija VTE- nije potrebna prilagodba doziranja u bolesnika s blagim ili umjerenim jetrenim oštećenjem.
Prevention of VTE- No dosing adjustment is necessary in patients with either mild or moderate hepatic impairment.

Izloženost valdekoksibu u plazmi(AUC i Cmax) bila je povećana(38% odnosno 24%) kad se istodobno primjenjivao ketokonazol(inhibitor CYP3A4), međutim, prilagodba doziranja općenito ne bi trebala biti neophodna u bolesnika koji primaju ketokonazol.
Plasma exposure(AUC and Cmax) to valdecoxib was increased(38% and 24%, respectively) when co- administered with ketoconazole(CYP3A4 inhibitor), however, a dosage adjustment should not generally be necessary for patients receiving ketoconazole.

Općenito nije potrebna prilagodba doziranja u bolesnika s blagim oštećenjem funkcije jetre Child-Pugh rezultat 5-6.
No dosage adjustment is generally necessary in patients with mild hepatic impairment Child-Pugh score 5-6.

Prevencija VTE- nije potrebna prilagodba doziranja fondaparinuksa.
Prevention of VTE- Dosing adjustment of fondaparinux is not necessary.

Nije potrebna prilagodba doziranja u starijih bolesnika s vrijednostima klirensa kreatinina> 50 ml/min vidjeti dio 5.2.
No dosage adjustment is required for the elderly with creatinine clearance values> 50 ml/min see section 5.2.

Prevencija VTE i liječenje UA/NSTEMI i STEMI- nije potrebna prilagodba doziranja u bolesnika s blagim ili umjerenim jetrenim oštećenjem.
Prevention of VTE and Treatment of UA/NSTEMI and STEMI- No dosing adjustment is necessary in patients with either mild or moderate hepatic impairment.

Na temelju farmakokinetike, nije potrebna prilagodba doziranja u bolesnika s blagim do umjerenim oštećenjem funkcije bubrega klirens kreatinina od 30-80 ml/min.
On the basis of pharmacokinetics, no dose adjustment is necessary in patients with mild to moderate renal impairment creatinine clearance of 30-80 ml/min.

Prilagodbe doziranja ili prekid liječenja lijekom OLYSIO.
Dosage adjustment or interruption of OLYSIO treatment.

Nema preporučene prilagodbe doziranja.
No dose adjustment is recommended.

Nema preporučenih prilagodbi doziranja.
No dose adjustment is recommended.

Nema preporučene prilagodbe doziranja.
No dose adjustment is required.

Prilagodbe doziranja u starijih bolesnika nisu neophodne ≥ 65 godina starosti.
Dosage adjustments are not required in elderly patients≥ 65 years old.

Za prilagodbu doziranja kapecitabina pogledati sažetak opisa svojstava tog lijeka.
For capecitabine dose modifications, see capecitabine summary of product characteristics.

Prilagodbe doziranja nisu potrebne u bolesnika koji postanu nepokretni.
No dosing adjustment is needed for patients who are becoming nonambulatory.

Tablica 1: Preporučene* prilagodbe doziranja kod neuropatije povezane s bortezomibom.
Table 1: Recommended* posology modifications for bortezomib-related neuropathy.

Prilagodbe doziranja ili prekid uzimanja lijekova koji se uzimaju u kombinaciji s lijekom OLYSIO za liječenje kroničnog hepatitisa C.
Dosage adjustment or interruption of medicinal products used in combination with OLYSIO for the treatment of CHC.

Također se ne mogu provoditi prilagodbe doziranja Aptivus kapsula za djecu ispod 12 godina starosti.
Also, appropriate dose adjustments for children under 12 years cannot be achieved with Aptivus capsules.

Potrebne su prilagodbe doziranja u odraslih, adolescenata i djece s CrCL ≤ 50 ml/min vidjeti dio 4.2.
Dosage adjustments are required in adults, adolescents and children with CrCL≤ 50 ml/min see section 4.2.